Cargando…
Stereochemical control of nucleosome targeting by platinum-intercalator antitumor agents
Platinum-based anticancer drugs act therapeutically by forming DNA adducts, but suffer from severe toxicity and resistance problems, which have not been overcome in spite of decades of research. And yet defined chromatin targets have generally not been considered in the drug development process. Her...
Autores principales: | Chua, Eugene Y.D., Davey, Gabriela E., Chin, Chee Fei, Dröge, Peter, Ang, Wee Han, Davey, Curt A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477649/ https://www.ncbi.nlm.nih.gov/pubmed/25916851 http://dx.doi.org/10.1093/nar/gkv356 |
Ejemplares similares
-
DNA stretching in the nucleosome facilitates alkylation by an intercalating antitumour agent
por: Davey, Gabriela E., et al.
Publicado: (2010) -
Critical role of DNA intercalation in enzyme-catalyzed nucleotide flipping
por: Hendershot, Jenna M., et al.
Publicado: (2014) -
ZYH005, a novel DNA intercalator, overcomes all-trans retinoic acid resistance in acute promyelocytic leukemia
por: Tong, Qingyi, et al.
Publicado: (2018) -
AP-endonuclease 1 sculpts DNA through an anchoring tyrosine residue on the DNA intercalating loop
por: Hoitsma, Nicole M, et al.
Publicado: (2020) -
Modulation of cyclobutane thymine photodimer formation in T(11)-tracts in rotationally phased nucleosome core particles and DNA minicircles
por: Wang, Kesai, et al.
Publicado: (2017)